Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.27914 | 10 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.25378 | 10 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.25617 | 10 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.19556 | 10 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.19562 | 10 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.31229 | 10 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.53354 | 21 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.22945 | 10 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.22246 | 10 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.24239 | 10 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.23786 | 10 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.22043 | 10 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.24779 | 10 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.24515 | 10 |